Nexa® Syringe has been developed to respond to main challenges of Biologics by creating a containment environment suitable for sensitive drugs and enhancing syringe functionality to ensure Auto-injector compatibility.
Nexa® Syringes are available as prefillable solutions through our EZ-fill® platform.
Nexa® Answers to Main Challenges of Biologics
Increased drug-container compatibility
Ultra-low tungsten and glue residuals
Enhanced cosmetic quality, improved mechanical resistance
Advanced manufacturing and in-line inspection minimize the risk of breakages and rejects in downstream process
Consistent gliding and injection force
The optimized silicone-oil distribution along the barrel provides enhanced gliding performance
Nexa® syringes have been specifically designed to meet the dimensional requirements of autoinjectors and to ensure excellent mechanical resistance when compared to a standard syringe.
These durable properties derive from optimized product handling throughout the entire manufacturing process (no glass-to-glass contact and limited glass-to-metal contact).
Advanced in-line inspection carefully controls products, minimizing the risk of in-line breakages during fill-finish operations, and reducing the number of rejects.
| STAKED NEEDLE | LUER | ||
|---|---|---|---|
|
RNS |
NS |
ITC* |
|
| 1mL long | |||
| 1mL | |||
| 2.25mL | |||
| 3mL | |||
Available
Upcoming
* Additional formats of 1.25ml and 1.5ml are available upon request.
Proven compatibility with autoinjectors
Ensuring your successful and timely launch
Multi-site production with robust supply chain, flexibility, and resilience
Minimizing your Total Cost of Ownership via superior reliability
The following are trademarks of their respective owners: PremiumCoat® (Aptar), NeoFlex™ (Datwyler), FluroTec® (West Pharmaceutical Services), Aidaptus® (Owen Mumford), Molly® (SHL Medical), YpsoMate® (Ypsomed), and Safe’n’Sound® (Nemera).
Nexa® syringe is the preferred solution for biologic drug products.
Biologics
GLP-1s
High-value/Novel Vaccines